Efficacy of glucagon-like peptide-1 receptor agonists compared to dipeptidyl peptidase-4 inhibitors for the management of type 2 diabetes: A meta-analysis of randomized clinical trials-Reference-Cited by-同舟云学术

Efficacy of glucagon-like peptide-1 receptor agonists compared to dipeptidyl peptidase-4 inhibitors for the management of type 2 diabetes: A meta-analysis of randomized clinical trials

Published:2018-01-24 Issue: Volume:20 Page:68-76
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Tran Susan¹,Retnakaran Ravi¹²³,Zinman Bernard¹²³,Kramer Caroline K.¹²^ORCID

Affiliation:

1. Leadership Sinai Centre for Diabetes; Mount Sinai Hospital; Toronto Canada

2. Division of Endocrinology; University of Toronto; Toronto Canada

3. Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Toronto Canada

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13137/fullpdf

Reference50 articles.

1. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes;Kahn;Diabetologia,2003

2. Pharmacologic approaches to glycemic treatment;American Diabetes Association;Diabetes Care,2017

3. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi;Diabetes Care,2015

4. Pharmacologic management of type 2 diabetes: 2016 interim update;Canadian Diabetes Association Clinical Practice Guidelines Expert Committee;Can J Diabetes,2016

5. National Institute for Health and Clinical Excellence 2016 https://www.nice.org.uk/guidance/ng28/resources/type-2-diabetes-in-adults-management-1837338615493

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of switching from dipeptidyl peptidase 4 inhibitors to oral semaglutide on oxidative stress and glycemic variability in patients with type 2 diabetes: an open-label, prospective, randomized, multicenter, parallel-group comparison study;2024-09-09

2. Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial;Diabetologia;2024-07-10

3. Improvement of β-Cell Function After Switching From DPP-4 Inhibitors to Oral Semaglutide: SWITCH-SEMA2 Post Hoc Analysis;The Journal of Clinical Endocrinology & Metabolism;2024-05-02

4. The benefits of GLP1 receptors in cardiovascular diseases;Frontiers in Clinical Diabetes and Healthcare;2023-12-08

5. Comparative effectiveness of second line glucose lowering drug treatments using real world data: emulation of a target trial;BMJ Medicine;2023-08